Study finds delay in follow-up among African-American women receiving abnormal breast findingOctober 26, 2009A new analysis has identified a significant delay in follow-up times among African-American women after the finding of a suspicious breast abnormality. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that African-American women may face obstacles to receiving appropriate breast cancer-related care. In the United States, and particularly South Carolina, African-American women suffer disproportionately higher mortality rates from breast cancer compared to white women. Studies have indicated that African-American women experience significantly longer time intervals from an abnormal mammogram to diagnostic testing or are less likely to comply with recommended diagnostic follow-up exams within six months of an abnormal mammogram. To investigate further, Swann Arp Adams, MS, PhD, of the University of South Carolina in Columbia, and her colleagues studied medical data from participants of the Best Chance Network, a state-wide service program that provides free mammography screenings to economically disadvantaged and medically underserved women. The program is part of the National Breast and Cervical Cancer Early Detection Program (NBCCEDP). Dr. Adams and her team analyzed tumor characteristics and patients' adherence to recommended tests following abnormal mammograms. While African-American women were just as likely as white women to complete diagnostic procedures after abnormal mammography findings, there was a significantly longer time between the first clinical exam and to complete a diagnostic follow-up (median time = 44 days for African Americans and 40 days for European Americans). When time was measured in the number of days between the mammogram and the date of final status, a significant effect of race was no longer evident. Because the clinical breast examination typically precedes the diagnostic mammogram, these findings suggest that the racial differences may occur early in the process. While the reasons for the delay are unknown, they may result from poor communication between patient and doctor, lack of patient trust in her doctor, lack of transportation, proximity of clinics to the patient, and other factors. The researchers say evidence indicates delayed follow-up of breast abnormalities can result in detecting the breast cancer at a later stage, pointing to one study that found a delayed diagnosis of breast cancer of as little as three months is associated with lower survival than those with prompt follow-up. The researchers add that the finding of no disparities existing in the overall completion of the follow-up is an encouraging evaluation of the NBCCEDP, as it suggests that the program is making progress toward eliminating racial disparities in breast cancer and offer areas for strengthening. "Programs specially aimed at providing breast cancer screening to economically disadvantaged women like the National Breast and Cervical Cancer Early Detection Program are successful in eliminating some of the racial disparities seen in breast cancer," said Dr. Adams. "There are still improvements that could be made in the program to help identify and eliminate barriers to timely completion of testing procedures," she added. American Cancer Society |
|||||||||||||||||||||
| Related Breast Cancer Current Events and Breast Cancer News Articles UCLA researchers create 'fly paper' to capture circulating cancer cells Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor. Fertility procedures need not delay breast cancer treatment for younger women A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion. Coffee break: Compound brewing new research in colon, breast cancer A compound in coffee has been found to be estrogenic in studies by Texas AgriLife Research scientists. Drugs to treat anemia in cancer patients linked to thromboembolism Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. Discovery in worms by Queen's researchers points to more targeted cancer treatment Researchers at Queen's University have found a link between two genes involved in cancer formation in humans, by examining the genes in worms. The groundbreaking discovery provides a foundation for how tumor-forming genes interact, and may offer a drug target for cancer treatment. FDA approved leukemia drugs shows promise in ovarian cancer cells The drug Sprycel, approved for use by the U.S. Food and Drug Administration in patients with chronic myeloid leukemia, significantly inhibited the growth and invasiveness of ovarian cancer cells and also promoted their death, a study by researchers with UCLA's Jonsson Comprehensive Cancer Center found. Carnegie Mellon researchers link health-care debate to risk of dying in US and Europe The current health care debate in the United States is complicated. Trade-offs between heath care expenditures, lifestyle choices and life expectancy have been suggested but seldom clearly demonstrated. Scientists uncover new key to the puzzle of hormone therapy and breast cancer The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor for breast cancer. Breast density associated with increased risk of cancer recurrence A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study's results indicate that breast cancer patients with dense breasts may benefit from additional therapies following surgery, such as radiation. Researcher: 'Optical biopsy' for breast cancer increasingly accurate But women may not have to endure the medical costs, stress and potential complications that accompany such invasive biopsies forever. A University of Florida biomedical engineering researcher is making progress on an "optical biopsy" that has the potential to determine whether growths are cancerous without ever puncturing the skin. More Breast Cancer Current Events and Breast Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||